Joe B. Putnam

Active 1983–2020

83
Papers
18,892
Citations
78
h-index
83
i10-index

Citations

Citations per year for Joe B. Putnam1971: 1 citations1976: 1 citations1984: 1 citations1985: 2 citations1986: 7 citations1987: 3 citations1988: 1 citations1989: 3 citations1990: 4 citations1991: 10 citations1992: 14 citations1993: 13 citations1994: 12 citations1995: 35 citations1996: 29 citations1997: 46 citations1998: 37 citations1999: 67 citations2000: 79 citations2001: 104 citations2002: 135 citations2003: 133 citations2004: 128 citations2005: 115 citations2006: 155 citations2007: 159 citations2008: 104 citations2009: 131 citations2010: 117 citations2011: 120 citations2012: 100 citations2013: 118 citations2014: 90 citations2015: 69 citations2016: 63 citations2017: 58 citations2018: 67 citations2019: 279 citations2020: 294 citations2021: 219 citations2022: 164 citations2023: 91 citations2024: 153 citations2025: 56 citations1972–1975: no citations, so these years are not shown1977–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,559 citing papers, 36.2% of this breakdownChina: 327 citing papers, 7.6% of this breakdownJapan: 261 citing papers, 6.1% of this breakdownUnited Kingdom: 260 citing papers, 6% of this breakdownGermany: 205 citing papers, 4.8% of this breakdownItaly: 204 citing papers, 4.7% of this breakdownCanada: 196 citing papers, 4.6% of this breakdownNetherlands: 166 citing papers, 3.9% of this breakdownFrance: 157 citing papers, 3.7% of this breakdownAustralia: 100 citing papers, 2.3% of this breakdownSpain: 86 citing papers, 2% of this breakdownSwitzerland: 83 citing papers, 1.9% of this breakdown
0%36.2%Other 16.2%

Fields

  • Medicine86.9%
  • Biochemistry, Genetics and Molecular Biology9.8%
  • Physics and Astronomy0.9%
  • Immunology and Microbiology0.6%
  • Engineering0.3%
  • Health Professions0.3%
  • Other1.2%

Topics

  • Lung Cancer Diagnosis and Treatment12.9%
  • Lung Cancer Treatments and Mutations5.8%
  • Esophageal Cancer Research and Treatment4%
  • Hepatocellular Carcinoma Treatment and Prognosis3.9%
  • Lung Cancer Research Studies3.2%
  • Pleural and Pulmonary Diseases2.6%
  • Other67.6%

Coauthors

All papers

Open in search
  1. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial

    Authors: , , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2011 cited by 762

  2. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases

    Authors: , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 1997 cited by 1,535

  3. Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 351

  4. Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial

    Authors: , , , , , , , , - Cancer 2015 cited by 224

  5. Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial

    Authors: , , , , , , , , - Journal of Clinical Oncology 2010 cited by 246

  6. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients

    Authors: , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2004 cited by 350

  7. Accuracy of FDG-PET to Diagnose Lung Cancer in Areas With Infectious Lung Disease

    Authors: , , , , , , , , , - JAMA 2014 cited by 190

  8. Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer

    Authors: , , , , , , , , , , , - The Annals of Thoracic Surgery 2020 cited by 53

  9. A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer

    Authors: , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 1994 cited by 1,117

  10. Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 2018 cited by 80

  11. Video-assisted thoracic surgery versus open lobectomy for lung cancer: A secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial

    Authors: , , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2010 cited by 368

  12. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report

    Authors: , , , , , , , , , , , , - Lung Cancer 2004 cited by 322

  13. Segmentectomy Versus Wedge Resection for Non-Small Cell Lung Cancer in High-Risk Operable Patients

    Authors: , , , , , , , , , , , - The Annals of Thoracic Surgery 2013 cited by 118

  14. Impact of Brachytherapy on Local Recurrence Rates After Sublobar Resection: Results From ACOSOG Z4032 (Alliance), a Phase III Randomized Trial for High-Risk Operable Non–Small-Cell Lung Cancer

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 114

  15. Occult Metastases in Lymph Nodes Predict Survival in Resectable Non–Small-Cell Lung Cancer: Report of the ACOSOG Z0040 Trial

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 107

  16. Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 1996 cited by 703

  17. Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial

    Authors: , , , , , , , , , , , - The Annals of Thoracic Surgery 2006 cited by 675

  18. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

    Authors: , , , , , , , , , , - Lung Cancer 1998 cited by 450

  19. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions

    Authors: , , , , , , , , , - Cancer 1999 cited by 381

  20. Management of Primary Pulmonary Artery Sarcomas

    Authors: , , , , , , , , , , , - The Annals of Thoracic Surgery 2009 cited by 266

  21. Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Waugh - JNCI Journal of the National Cancer Institute 1999 cited by 497

  22. Survival in early-stage non-small cell lung cancer

    Authors: , , , , - The Annals of Thoracic Surgery 1995 cited by 382

  23. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katherine M.W. Pisters, Joe B. Putnam, Arcenio J. Sarabia, Thomas Shelton, Craig Stevens, Daniel M. Shin, W. Roy Smythe, Ara A. Vaporciyan, Garrett L. Walsh, Min Yin - 2003 cited by 217

  24. Cationic Liposome-MediatedE1AGene Transfer to Human Breast and Ovarian Cancer Cells and Its Biologic Effects: A Phase I Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2001 cited by 209